SCHEDULE 13G/A
SCHEDULE 13G/ASchedule 13G ownership disclosure
ELEDON PHARMACEUTICALS INC COM
Common Stock · CUSIP: 28617K101
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Frazier Life Sciences Public Fund, L.P.
Shares: 878,080.00 · Class: 1.5%
- FHMLSP, L.P.
Shares: 878,080.00 · Class: 1.5%
- FHMLSP, L.L.C.
Shares: 878,080.00 · Class: 1.5%
- Frazier Life Sciences Public Overage Fund, L.P.
Shares: 258,998.00 · Class: 0.4%
- FHMLSP Overage, L.P.
Shares: 258,998.00 · Class: 0.4%
- FHMLSP Overage, L.L.C.
Shares: 258,998.00 · Class: 0.4%
- Frazier Life Sciences X, L.P.
Shares: 13,062.00 · Class: 0.0%
- FHMLS X, L.P.
Shares: 13,062.00 · Class: 0.0%
- FHMLS X, L.L.C.
Shares: 13,062.00 · Class: 0.0%
- Frazier Life Sciences XI, L.P.
Shares: 26,595.00 · Class: 0.0%
- FHMLS XI, L.P.
Shares: 26,595.00 · Class: 0.0%
- FHMLS XI, L.L.C.
Shares: 26,595.00 · Class: 0.0%
- James N. Topper
Shares: 1,176,735.00 · Class: 2.0%
- Patrick J. Heron
Shares: 1,176,735.00 · Class: 2.0%
- Albert Cha
Shares: 1,137,078.00 · Class: 1.9%
- James Brush
Shares: 1,137,078.00 · Class: 1.9%
- Daniel Estes
Shares: 26,595.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-003986
- Form type
- SCHEDULE 13G/A
- Filer
- Eledon Pharmaceuticals, Inc.
- CIK
- CIK 1404281
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership